ACOR

Acorda Therapeutics
ACOR

Overview Fund Trends Analyst Outlook Journalist POV
Delisted

ACOR was delisted on the 11th of April, 2024.

Back to rankings

175 hedge funds and large institutions have $899M invested in Acorda Therapeutics in 2016 Q4 according to their latest regulatory filings, with 28 funds opening new positions, 59 increasing their positions, 57 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding

Funds holding: →

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more funds holding in top 10

Funds holding in top 10: →

11% less capital invested

Capital invested by funds: $1.01B → $899M (-$108M)

83% less call options, than puts

Call options by funds: $7.01M | Put options by funds: $40.8M

Holders
175
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$7.01M
Puts
$40.8M
Net Calls
Net Calls Change

Top Buyers

1
+$13.5M
2
+$11.8M
3
+$6.17M
4
SM
Sabby Management
Florida
+$4.96M
5
Millennium Management
Millennium Management
New York
+$4.58M

Top Sellers

1
-$13M
2
-$10.3M
3
-$8.01M
4
Westfield Capital Management
Westfield Capital Management
Massachusetts
-$7.43M
5
Goldman Sachs
Goldman Sachs
New York
-$7.15M
Name Holding Trade Value Shares
Change 		Change in
Stake
26
$7.06M
27
$6.61M
28
$6.56M
29
$6.47M
30
$6.38M
31
$6.16M
32
$6M
33
$5.43M
34
$5.19M
35
$4.96M
36
$4.73M
37
$4.71M
38
$4.43M
39
$4.11M
40
$4.09M
41
$3.72M
42
$3.61M
43
$3.36M
44
$3.08M
45
$2.99M
46
$2.97M
47
$2.86M
48
$2.79M
49
$2.75M
50
$2.63M
1
2
3 4 5